Mirae Asset Global Investments’s Shockwave Medical, Inc. Common Stock SWAV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-15,765
Closed -$3.41M 2671
2024
Q1
$3.41M Buy
+15,765
New +$3.87M 0.01% 993
2023
Q2
Sell
-15,762
Closed -$3.42M 2722
2023
Q1
$3.42M Buy
15,762
+196
+1% +$38.2K 0.01% 969
2022
Q4
$3.2M Buy
15,566
+150
+1% +$37.9K 0.01% 952
2022
Q3
$4.29M Buy
15,416
+788
+5% +$200K 0.01% 862
2022
Q2
$2.8M Buy
+14,628
New +$2.58M 0.01% 1032

Other funds holding SWAV

Mirae Asset Global Investments's SWAV Position: Q2 2024 in Review

Mirae Asset Global Investments sold out of Shockwave Medical, Inc. Common Stock (SWAV) in Q2 2024, closing a stake of 15,765 shares — an estimated $3.41M sold.

Mirae Asset Global Investments first reported a position in SWAV in Q2 2022 and held it in 5 quarters. The position peaked at $4.29M in Q3 2022. 7 funds tracked by Wall St. Rank hold SWAV as of Q2 2024.

  • Mirae Asset Global Investments reported no remaining Shockwave Medical, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
  • Mirae Asset Global Investments sold 15,765 Shockwave Medical, Inc. Common Stock shares in Q2 2024, an estimated $3.41M.
  • Mirae Asset Global Investments first reported a position in Shockwave Medical, Inc. Common Stock in Q2 2022 and held it in 5 quarters.
  • Mirae Asset Global Investments's Shockwave Medical, Inc. Common Stock position peaked at $4.29M in Q3 2022.
  • 7 funds tracked by Wall St. Rank held Shockwave Medical, Inc. Common Stock as of Q2 2024.

Based on Mirae Asset Global Investments's 13F filing for Q2 2024, filed 30 Jul 2024.